Albiglutide Fragment

For research use only.

Catalog No.S3734

Albiglutide Fragment Chemical Structure

CAS No. 782500-75-8

Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).

Purity & Quality Control

Choose Selective Glucagon Receptor Inhibitors

Biological Activity

Description Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).
In vitro

Albiglutide is a recombinant fusion protein consisting of two copies of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36), modified with a glycine substituted for the naturally occurring alanine at position 8 in order to augment resistance to DPP-4[1].

In vivo

Glucose lowering occurs within 24 h after a single dose of albiglutide, as a result of binding of the molecule to the GLP-1 receptor. The reduction in both fasting and postprandial glucose levels is dose related. Albiglutide is less potent than GLP-1. In animal models of diabetes, albiglutide administration stimulates increased β-cell mass. Following SC administration of a single 30-mg dose to patients with type 2 diabetes, maximum concentration is reached in 3-5 days with half-life of 3.6-6.8 days. The apparent volume of distribution after a single dose of albiglutide was 8.2-18.5 L. The eventual fate of albiglutide in the circulation is degradation into small peptides and individual amino acids. Albiglutide had no apparent effects on cardiovascular function, heart rate, electrocardiographic intervals, or respiratory function and did not produce any evidence of electrocardiographic abnormalities or arrhythmias in male cynomolgus monkeys. Furthermore, there were no albiglutide-related effects on neurobehavioral functional assessments. Albiglutide does not cross the blood–brain barrier to reach the satiety centers[1]. Albiglutide reduced myocardial infarct size and improved cardiac function and energetics following myocardial I/R injury which are associated with enhanced myocardial glucose uptake and a shift toward a more energetically favorable substrate metabolism by increasing both glucose and lactate oxidation[2].

Protocol

Animal Research:

[2]

- Collapse
  • Animal Models: Male Sprague-Dawley rats
  • Dosages: 1, 3 or 10 mg/kg/day
  • Administration: s.c.
    (Only for Reference)

Solubility (25°C)

In vitro Water 100 mg/mL (30.45 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 3283.6
Formula

C148H224N40O45

CAS No. 782500-75-8
Storage powder
in solvent
Synonyms N/A
Smiles CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)䲧瘆Ỵ瘇㧀瘅膉疴睥๰ઇី'ઇĀ㺣疲帉疲Ѐ瑖猗﫜돸ቬઇĀ鄸ቬ彿猘奋猘巫猘쟜ቬ쫀ቬ彿猘쪴ቬ塚猘쫀ቬꍈ猝돸ቬ學猘漸猝圔猘돸ቬ圞猘圭猘﫜玚Wី' ី'戤睕$ଐ঵䐺疲暼睥ଐ঵ី' ଐ঵ð㺣疲ଐ঵€﫜ଔ঵€

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03015519 Withdrawn Drug: Albiglutide|Drug: Placebo Diabetes Mellitus Type 2 GlaxoSmithKline August 14 2017 Phase 3
NCT02750930 Terminated Drug: Albiglutide|Device: Auto-injector Diabetes Mellitus Type 2 GlaxoSmithKline October 7 2016 Phase 4
NCT02229227 Completed Drug: Albiglutide|Drug: Insulin Glargine and Insulin Lispro Diabetes Mellitus Type 2 GlaxoSmithKline|PPD November 21 2014 Phase 3
NCT01475734 Completed Biological: albiglutide|Biological: placebo Diabetes Mellitus Type 2 GlaxoSmithKline December 2011 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Albiglutide Fragment | Albiglutide Fragment ic50 | Albiglutide Fragment price | Albiglutide Fragment cost | Albiglutide Fragment solubility dmso | Albiglutide Fragment purchase | Albiglutide Fragment manufacturer | Albiglutide Fragment research buy | Albiglutide Fragment order | Albiglutide Fragment mouse | Albiglutide Fragment chemical structure | Albiglutide Fragment mw | Albiglutide Fragment molecular weight | Albiglutide Fragment datasheet | Albiglutide Fragment supplier | Albiglutide Fragment in vitro | Albiglutide Fragment cell line | Albiglutide Fragment concentration | Albiglutide Fragment nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID